RxDoctor Payments Data

Rebecca Lu, MD

MOHS-Micrographic Surgery · Warren, NJNPI 1144483116

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by LEO Pharma Inc. at 38.6% of the total. Reporting peaked in 2019 at $496 and has fallen 92.5% since, to $37 in 2024.

$1,165in general payments, 2019–2025

Across 94 payments — averaging $12.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • LEO Pharma Inc.$450
  • GSK$250
  • AbbVie$126
  • Almirall LLC$79
  • Mayne Pharma Commercial LLC$48
  • Sun Pharmaceutical Industries Inc.$38
  • plus $174 from 9 others

What the payments were for

  • Food & beverage$1,165100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,165 in reported general payments places this provider in the 55th percentile of 30 mohs-micrographic surgery providers in New Jersey.

See all mohs-micrographic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$675,018
Medicare patients
496
Services billed
5,539

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate64$2,589
Mupirocin269$1,858
Metronidazole27$1,111
Cephalexin197$868
Triamcinolone Acetonide114$805
Doxycycline Hyclate48$577
CiclopiroxCiclopirox Olamine36$518
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip31$343
CefuroximeCefuroxime Axetil35$272
Hydrocortisone Valerate11$219
Azithromycin41$135
Tramadol Hcl14$34

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Warren

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →